Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Wasif Saif

Showing results (321-330 of 473) with videos related to

Pageof 48
Sort By:
JOP : Journal of the Pancreas|July 13, 2013
Prognostic factors in pancreatic cancerGeorgios Michael Oikonomopoulos, Konstantinos N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 13, 2013
New therapeutic strategies in the second line setting of advanced or metastatic pancreatic adenocarcinomaVasilis Stefanos Ramfidis, Kostas N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 13, 2013
Pharmacogenomics in pancreatic adenocarcinoma: new data and their clinical implicationsAlexios S Strimpakos, Kostas N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 17, 2012
Clinical and laboratory biomarkers in the management of pancreatic adenocarcinomaAlexios S Strimpakos, Kostas N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 9, 2011
Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Haiying Cheng, Eirini Merika, Kostas N Syrigos, et al.
Clinical Colorectal Cancer|January 7, 2011
Safety and efficacy of panitumumab therapy after progression with cetuximab: experience at two institutionsMuhammad Wasif Saif, Kristin Kaley, Edward Chu, et al.
JOP : Journal of the Pancreas|July 6, 2010
Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Jia Li, Man Yee Merl, John Chabot, et al.
JOP : Journal of the Pancreas|July 6, 2010
First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Man Yee Merl, Osama Abdelghany, Jia Li, et al.
Cancer Medicine Journal|February 26, 2021
Retrospective Analysis of Patients with Gynecological Uterine Sarcomas: Leiomyosarcomas and other Histological Subtypes at a Single Institution from 1996 to 2015Olger Nano, Maria J Nieto, Muhammad Wasif Saif, et al.
JOP : Journal of the Pancreas|July 13, 2013
Biomarkers in neuroendocrine tumorsMarvin Duque, Irvin M Modlin, Anumeha Gupta, et al.
Pageof 48

Showing results (321-330 of 473) with videos related to

Sort By:
Pageof 48
JOP : Journal of the Pancreas|July 13, 2013
Prognostic factors in pancreatic cancerGeorgios Michael Oikonomopoulos, Konstantinos N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 13, 2013
New therapeutic strategies in the second line setting of advanced or metastatic pancreatic adenocarcinomaVasilis Stefanos Ramfidis, Kostas N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 13, 2013
Pharmacogenomics in pancreatic adenocarcinoma: new data and their clinical implicationsAlexios S Strimpakos, Kostas N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 17, 2012
Clinical and laboratory biomarkers in the management of pancreatic adenocarcinomaAlexios S Strimpakos, Kostas N Syrigos, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 9, 2011
Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Haiying Cheng, Eirini Merika, Kostas N Syrigos, et al.
Clinical Colorectal Cancer|January 7, 2011
Safety and efficacy of panitumumab therapy after progression with cetuximab: experience at two institutionsMuhammad Wasif Saif, Kristin Kaley, Edward Chu, et al.
JOP : Journal of the Pancreas|July 6, 2010
Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Jia Li, Man Yee Merl, John Chabot, et al.
JOP : Journal of the Pancreas|July 6, 2010
First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Man Yee Merl, Osama Abdelghany, Jia Li, et al.
Cancer Medicine Journal|February 26, 2021
Retrospective Analysis of Patients with Gynecological Uterine Sarcomas: Leiomyosarcomas and other Histological Subtypes at a Single Institution from 1996 to 2015Olger Nano, Maria J Nieto, Muhammad Wasif Saif, et al.
JOP : Journal of the Pancreas|July 13, 2013
Biomarkers in neuroendocrine tumorsMarvin Duque, Irvin M Modlin, Anumeha Gupta, et al.
Pageof 48